(IBDX) iShares Trust - iShares - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US46436E3128 • Target Maturity

IBDX: Fixed, Income, Securities, Corporate, Bonds, Target, Maturity

The iShares iBonds Dec 2032 Term Corporate ETF (IBDX) is designed to track the performance of investment-grade corporate bonds maturing in 2032. The fund may invest in securities of non-U.S. issuers to align with its underlying index. It allocates at least 80% of its assets to index components and at least 90% to fixed income securities consistent with the index. The ETF is non-diversified, meaning it can concentrate holdings in fewer issuers.

Technically, IBDX shows a sideways trend with support near its 20-day SMA of 24.58 and resistance at its 50-day SMA of 24.65. The 200-day SMA at 24.45 suggests longer-term stability. Average trading volume of 133,400 shares indicates moderate liquidity. The ATR of 0.21 reflects low price volatility. Fundamentally, with AUM of $1.022 billion, the ETF demonstrates investor interest in its target maturity strategy. Expect IBDX to remain range-bound near current levels, with potential upside driven by its alignment to the 20-day SMA and continued demand for corporate bonds with defined maturities.

Additional Sources for IBDX ETF

IBDX ETF Overview

Market Cap in USD 1,022m
Category Target Maturity
TER 0.10%
IPO / Inception 2022-06-28

IBDX ETF Ratings

Growth Rating 40.8
Fundamental -
Dividend Rating 67.8
Rel. Strength -3.72
Analysts -
Fair Price Momentum 24.77 USD
Fair Price DCF -

IBDX Dividends

Dividend Yield 12m 4.64%
Yield on Cost 5y 5.18%
Annual Growth 5y 28.83%
Payout Consistency 100.0%

IBDX Growth Ratios

Growth Correlation 3m 35.4%
Growth Correlation 12m 57.7%
Growth Correlation 5y 84.7%
CAGR 5y 4.18%
CAGR/Max DD 5y 0.33
Sharpe Ratio 12m 0.55
Alpha 2.21
Beta 0.019
Volatility 7.38%
Current Volume 120.5k
Average Volume 20d 122.1k
What is the price of IBDX stocks?
As of May 09, 2025, the stock is trading at USD 24.70 with a total of 120,456 shares traded.
Over the past week, the price has changed by -0.36%, over one month by +1.74%, over three months by +1.38% and over the past year by +6.53%.
Is iShares Trust - iShares a good stock to buy?
Partly, yes. Based on ValueRay Analyses, iShares Trust - iShares (NYSE ARCA:IBDX) is currently (May 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 40.78 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IBDX as of May 2025 is 24.77. This means that IBDX is currently overvalued and has a potential downside of 0.28%.
Is IBDX a buy, sell or hold?
iShares Trust - iShares has no consensus analysts rating.
What are the forecast for IBDX stock price target?
According to ValueRays Forecast Model, IBDX iShares Trust - iShares will be worth about 26.8 in May 2026. The stock is currently trading at 24.70. This means that the stock has a potential upside of +8.3%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 26.8 8.3%